StAR-related lipid transfer domain protein 5 binds primary bile acids

Journal of Lipid Research

Volumn 53, Issue 12, 2012, Pages 2677-2689

  Let́ourneau, Danny ^a   Lorin, Aurélien ^a   Lefebvre, Andrée ^a   Frappier, Vincent ^a   Gaudreault, Francis ^a   Najmanovich, Rafael ^a   Lavigne, Pierre ^a   LeHoux, Jean Guy ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Bile acids; Cholesterol metabolism; Circular dichroism; Isothermal titration calorimetry; Lipid transport; NMR spectroscopy; Steroidogenic acute regulatory protein

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; FARNESOID X RECEPTOR; LIPID TRANSFER PROTEIN; STEROIDOGENIC ACUTE REGULATORY RELATED LIPID TRANSFER DOMAIN PROTEIN 5; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL TRANSPORT; CIRCULAR DICHROISM; HETERONUCLEAR SINGLE QUANTUM COHERENCE; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 84869020761     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M031245     Document Type: Article

References (70)

1. Hylemon, P. B., R. T. Stravitz, and Z. R. Vlahcevic. 1994. Molecular genetics and regulation of bile acid biosynthesis. Prog. Liver Dis. 12: 99-120.
2. Russell, D. W. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174.
3. Soccio, R. E., and J. L. Breslow. 2004. Intracellular cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 24: 1150-1160.
4. Alpy, F., and C. Tomasetto. 2005. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 118: 2791-2801.
5. Ponting, C. P., and L. Aravind. 1999. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem. Sci.24: 130-132.
6. Rodriguez-Agudo, D., S. Ren, P. B. Hylemon, K. Redford, R. Natarajan, A. Del Castillo, G. Gil, and W. M. Pandak. 2005. Human StarD5, a cytosolic StAR-related lipid binding protein. J. Lipid Res.46: 1615-1623.
7. Strauss 3rd, J. F., T. Kishida, L. K. Christenson, T. Fujimoto, and H. Hiroi. 2003. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell. Endocrinol.202: 59-65.
8. Iyer, L. M., E. V. Koonin, and L. Aravind. 2001. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins. 43: 134-144.
9. Kudo, N., K. Kumagai, R. Matsubara, S. Kobayashi, K. Hanada, S. Wakatsuki, and R. Kato. 2010. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J. Mol. Biol. 396: 245-251.
10. Kudo, N., K. Kumagai, N. Tomishige, T. Yamaji, S. Wakatsuki, M. Nishijima, K. Hanada, and R. Kato. 2008. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc. Natl. Acad. Sci. USA. 105: 488-493.
11. Lavigne, P., R. Najmanivich, and J. G. Lehoux. 2010. Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding. Subcell. Biochem. 51: 425-437.
12. Mathieu, A. P., P. Lavigne, and J. G. LeHoux. 2002. Molecular modeling and structure-based thermodynamic analysis of the StAR protein. Endocr. Res. 28: 419-423.
13. Roderick, S. L., W. W. Chan, D. S. Agate, L. R. Olsen, M. W. Vetting, K. R. Rajashankar, and D. E. Cohen. 2002. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat. Struct. Biol. 9: 507-511.
14. Romanowski, M. J., R. E. Soccio, J. L. Breslow, and S. K. Burley. 2002. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc. Natl. Acad. Sci. USA. 99: 6949-6954.
15. Thorsell, A. G., W. H. Lee, C. Persson, M. I. Siponen, M. Nilsson, R. D. Busam, T. Kotenyova, H. Schuler, and L. Lehtio. 2011. Comparative structural analysis of lipid binding START domains. PLoS ONE. 6: e19521.
16. Tsujishita, Y., and J. H. Hurley. 2000. Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 7: 408-414.
17. Clark, B. J. 2012. The mammalian START domain protein family in lipid transport in health and disease. J. Endocrinol. 212: 257-275.
18. Soccio, R. E., R. M. Adams, M. J. Romanowski, E. Sehayek, S. K. Burley, and J. L. Breslow. 2002. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc. Natl. Acad. Sci. USA.99: 6943-6948.
19. Bens, S., A. Mohn, B. Yuksel, A. E. Kulle, M. Michalek, F. Chiarelli, M. Nuri Ozbek, I. Leuschner, J. Grotzinger, P. M. Holterhus, et al. 2010. Congenital lipoid adrenal hyperplasia: functional characterization of three novel mutations in the STAR gene. J. Clin. Endocrinol. Metab. 95: 1301-1308.
20. Bhangoo, A., W. X. Gu, S. Pavlakis, H. Anhalt, L. Heier, S. Ten, and J. L. Jameson. 2005. Phenotypic features associated with mutations in steroidogenic acute regulatory protein. J. Clin. Endocrinol. Metab.90: 6303-6309.
21. Bose, H. S., T. Sugawara, J. F. Strauss 3rd, and W. L. Miller. 1996. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl. J. Med. 335: 1870-1878.
22. Chen, X., B. Y. Baker, M. A. Abduljabbar, and W. L. Miller. 2005. A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings. J. Clin. Endocrinol. Metab. 90: 835-840.
23. Clark, B. J., J. Wells, S. R. King, and D. M. Stocco. 1994. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269: 28314-28322.
24. Flück, C. E., A. V. Pandey, B. Dick, N. Camats, M. Fernandez- Cancio, M. Clemente, M. Gussinye, A. Carrascosa, P. E. Mullis, and L. Audi. 2011. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS ONE. 6: e20178.
25. Gassner, H. L., J. Toppari, S. Quinteiro Gonzalez, and W. L. Miller. 2004. Near-miss apparent SIDS from adrenal crisis. J. Pediatr. 145: 178-183.
26. Katsumata, N., Y. Kawada, Y. Yamamoto, M. Noda, A. Nimura, R. Horikawa, and T. Tanaka. 1999. A novel compound heterozygous mutation in the steroidogenic acute regulatory protein gene in a patient with congenital lipoid adrenal hyperplasia. J. Clin. Endocrinol. Metab. 84: 3983-3987.
27. Khoury, J., A. L. Amundsen, S. Tonstad, T. Henriksen, L. Ose, K. Retterstol, and P. O. Iversen. 2009. Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia. Acta Obstet. Gynecol. Scand. 88: 222-226.
28. Lehoux, J. G., A. Mathieu, P. Lavigne, and A. Fleury. 2003. Adrenocorticotropin regulation of steroidogenic acute regulatory protein. Microsc. Res. Tech. 61: 288-299.
29. Lin, D., T. Sugawara, J. F. Strauss 3rd, B. J. Clark, D. M. Stocco, P. Saenger, A. Rogol, and W. L. Miller. 1995. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 267: 1828-1831.
30. Nakae, J., T. Tajima, T. Sugawara, F. Arakane, K. Hanaki, T. Hotsubo, N. Igarashi, Y. Igarashi, T. Ishii, N. Koda, et al. 1997. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum. Mol. Genet. 6: 571-576.
31. Hall, E. A., S. Ren, P. B. Hylemon, D. Rodriguez-Agudo, K. Redford, D. Marques, D. Kang, G. Gil, and W. M. Pandak. 2005. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. Biochim. Biophys. Acta. 1733: 111-119.
32. Pandak, W. M., S. Ren, D. Marques, E. Hall, K. Redford, D. Mallonee, P. Bohdan, D. Heuman, G. Gil, and P. Hylemon. 2002. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem. 277: 48158-48164.
33. Sugawara, T., D. Lin, J. A. Holt, K. O. Martin, N. B. Javitt, W. L. Miller, and J. F. Strauss 3rd. 1995. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry. 34: 12506-12512.
34. Alpy, F., and C. Tomasetto. 2006. MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem. Soc. Trans. 34: 343-345.
35. Rodriguez-Agudo, D., S. Ren, E. Wong, D. Marques, K. Redford, G. Gil, P. Hylemon, and W. M. Pandak. 2008. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J. Lipid Res. 49: 1409-1419.
36. Chang, I. Y., J. K. Kim, S. M. Lee, J. N. Kim, J. Soh, J. W. Kim, and S. P. Yoon. 2009. The changed immunoreactivity of StarD6 after pilocarpine-induced epilepsy. Neuroreport. 20: 963-967.
37. Chang, I. Y., S. Y. Shin, J. W. Kim, J. M. Yu, J. S. Kim, P. I. Song, and S. P. Yoon. 2007. The changed immunolocalization of START-domain-containing 6 (StarD6) during the development of testes in rat perinatal hypothyroidism. Acta Histochem. 109: 315-321.
38. Gomes, C., S. D. Oh, J. W. Kim, S. Y. Chun, K. Lee, H. B. Kwon, and J. Soh. 2005. Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol. Reprod. 72: 651-658.
39. Chang, I. Y., Y. J. Jeon, S. M. Jung, Y. H. Jang, J. B. Ahn, K. S. Park, and S. P. Yoon. 2010. Does the StarD6 mark the same as the StAR in the nervous system? J. Chem. Neuroanat. 40: 239-242.
40. Chang, I. Y., J. H. Kim, G. Hwang, P. I. Song, R. J. Song, J. W. Kim, and S. P. Yoon. 2007. Immunohistochemical detection of StarD6 in the rat nervous system. Neuroreport. 18: 1615-1619.
41. Chang, I. Y., T. Ohn, G. S. Ko, Y. Yoon, J. W. Kim, and S. P. Yoon. 2012. Immunolocalization of steroidogenic acute regulatory protein-related lipid transfer (START) domain-containing proteins in the developing cerebellum of normal and hypothyroid rats. J. Chem. Neuroanat. 43: 28-33.
42. Elbadawy, H. M., F. Borthwick, C. Wright, P. E. Martin, and A. Graham. 2011. Cytosolic StAR-related lipid transfer domain 4 (STARD4) protein influences keratinocyte lipid phenotype and differentiation status. Br. J. Dermatol. 164: 628-632.
43. Rodriguez-Agudo, D., M. Calderon-Dominguez, S. Ren, D. Marques, K. Redford, M. A. Medina-Torres, P. Hylemon, G. Gil, and W. M. Pandak. 2011. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim. Biophys. Acta. 1811: 597-606.
44. Mesmin, B., N. H. Pipalia, F. W. Lund, T. F. Ramlall, A. Sokolov, D. Eliezer, and F. R. Maxfield. 2011. STARD4 abundance regulates sterol transport and sensing. Mol. Biol. Cell. 22: 4004-4015.
45. Chen, Y. C., R. K. Meier, S. Zheng, S. J. Khundmiri, M. T. Tseng, E. D. Lederer, P. N. Epstein, and B. J. Clark. 2009. Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules. Am. J. Physiol. Renal Physiol.297: F380-F388.
46. Rodriguez-Agudo, D., S. Ren, P. B. Hylemon, R. Montanez, K. Redford, R. Natarajan, M. A. Medina, G. Gil, and W. M. Pandak. 2006. Localization of StarD5 cholesterol binding protein. J. Lipid Res. 47: 1168-1175.
47. Soccio, R. E., R. M. Adams, K. N. Maxwell, and J. L. Breslow. 2005. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J. Biol. Chem. 280: 19410-19418.
48. Roostaee, A., E. Barbar, J. G. Lehoux, and P. Lavigne. 2008. Cholesterol binding is a prerequisite for the activity of the steroidogenic acute regulatory protein (StAR). Biochem. J. 412: 553-562.
49. Delaglio, F., S. Grzesiek, G. W. Vuister, G. Zhu, J. Pfeifer, and A. Bax. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6: 277-293.
50. Vranken, W. F., W. Boucher, T. J. Stevens, R. H. Fogh, A. Pajon, M. Llinas, E. L. Ulrich, J. L. Markley, J. Ionides, and E. D. Laue. 2005. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 59: 687-696.
51. Wishart, D. S., C. G. Bigam, J. Yao, F. Abildgaard, H. J. Dyson, E. Oldfield, J. L. Markley, and B. D. Sykes. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR.6: 135-140.
52. Gardner, K. H., M. K. Rosen, and L. E. Kay. 1997. Global folds of highly deuterated, methyl-protonated proteins by multidimensional NMR. Biochemistry. 36: 1389-1401.
53. Fielding, L. 2007. NMR methods for the determination of protein-ligand dissociation constants. Prog. Nucl. Magn. Reson. Spectrosc. 51: 219-242.
54. Hou, T., J. Wang, Y. Li, and W. Wang. 2011. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J. Comput. Chem. 32: 866-877.
55. Lorin, A., D. Letourneau, A. Lefebvre, J. G. Lehoux, and P. Lavigne. 2012. (1)H, (13)C, and (15)N backbone chemical shift assignments of StAR-related lipid transfer domain protein 5 (STARD5). Biomol. NMR Assign. Epub ahead of print. March 6, 2012; doi:10.1007/s12104-012-9368-z.
56. Wishart, D. S., and B. D. Sykes. 1994. Chemical shifts as a tool for structure determination. Methods Enzymol. 239: 363-392.
57. Wishart, D. S., and B. D. Sykes. 1994. The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J. Biomol. NMR. 4: 171-180.
58. Barbar, E., J. G. Lehoux, and P. Lavigne. 2009. Toward the NMR structure of StAR. Mol. Cell. Endocrinol. 300: 89-93.
59. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science.284: 1362-1365.
60. Wang, H., J. Chen, K. Hollister, L. C. Sowers, and B. M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3: 543-553.
61. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284: 1365-1368.
62. Mencarelli, A., B. Renga, E. Distrutti, and S. Fiorucci. 2009. Antiatherosclerotic effect of farnesoid X receptor. Am. J. Physiol. Heart Circ. Physiol. 296: H272-H281.
63. Jiang, T., X. X. Wang, P. Scherzer, P. Wilson, J. Tallman, H. Takahashi, J. Li, M. Iwahashi, E. Sutherland, L. Arend, et al. 2007. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes. 56: 2485-2493.
64. Sreerama, N., and R. W. Woody. 2004. Computation and analysis of protein circular dichroism spectra. Methods Enzymol. 383: 318-351.
65. Layton, C. J., and H. W. Hellinga. 2010. Thermodynamic analysis of ligand-induced changes in protein thermal unfolding applied to high-throughput determination of ligand affinities with extrinsic fluorescent dyes. Biochemistry. 49: 10831-10841.
66. Shuker, S. B., P. J. Hajduk, R. P. Meadows, and S. W. Fesik. 1996. Discovering high-affinity ligands for proteins: SAR by NMR. Science.274: 1531-1534.
67. Zuiderweg, E. R. 2002. Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry. 41: 1-7.
68. Lew, J. L., A. Zhao, J. Yu, L. Huang, N. De Pedro, F. Pelaez, S. D. Wright, and J. Cui. 2004. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J. Biol. Chem.279: 8856-8861.
69. Monte, M. J., J. J. Marin, A. Antelo, and J. Vazquez-Tato. 2009. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol.15: 804-816.
70. Lazaridis, T., G. Archontis, and M. Karplus. 1995. Enthalpic contribution to protein stability: insights from atom-based calculations and statistical mechanics. Adv. Protein Chem. 47: 231-306.